SEC Form D private-offering filing
NurExone Biologic Inc.
A new SEC Form D private-offering notice from Technion City, Haifa, a $441,779 filer-stated offering target in Biotech. The source filing is one click away.
Develops exosome based nanodrug therapies for central nervous system injuries, including its lead candidate ExoPTEN for acute spinal cord injury.
Filed 2026-07-02Filed to raise $441,779First money in 2026-06-30Raised so far $441,779HQ (as filed) Technion City, HaifaSector Biotech ✓Stage (inferred) Pre-seedCall status Needs classification
Source linked the Form D on EDGAR↗Website verified nurexone.com↗Named in the filing 6 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.